| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |